Many diagnoses of MPNs occur in patients that have acquired mutations in the Janus kinase 2 (JAK2) gene, seen in 95% of patients diagnosed with PV and over 50% of patients diagnosed with MF and ET) [15]. The gene discussed is JAK2; the disease is essential thrombocythemia.